Germline point mutations in the SMAD4 and BMPR1A genes have been reported in around 40% of patients with juvenile polyposis syndrome (JPS). We performed mutation analysis in 80 unrelated patients of whom 65 met the clinical criteria for JPS (typical JPS) and 15 were suspected to have JPS. By direct sequencing of the two genes we identified point mutations in 30 patients (46% of typical JPS). Using MLPA we detected large genomic SMAD4 or BMPR1A deletions in 14% of all patients with typical JPS (six deletions in SMAD4 and three deletions in BMPR1A). Thus, screening for large deletions raised the mutation detection rate to 60% in the 65 patients with typical JPS. Mutation analysis of the PTEN gene in the remaining 41 SMAD4 and BMPR1A mutation negative cases uncovered a point mutation in two patients (5%). We identified a strong genotype-phenotype correlation regarding gastric polyposis, gastric cancer, and hereditary hemorrhagic telangiectasia (HHT, Osler-Weber-Rendu disease) in JPS patients: SMAD4 mutation carriers had a significantly higher frequency of gastric polyposis (73%) compared to patients with BMPR1A mutations (8%) (p<0.001); all seven cases of gastric cancer occurred in families with SMAD4 mutations. SMAD4 mutation carriers with gastric polyps were significantly older at gastroscopy than those without gastric polyps (p<0.001). In 22% of the 23 unrelated SMAD4 mutation carriers, HHT was also diagnosed clinically. In many JPS patients with identified germline mutation, the documented histologic findings encompassed a wide distribution of different polyp types, comparable to that described in hereditary mixed polyposis syndromes (HMPS).
- Genomic deletions
- Juvenile polyposis syndrome
Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.